Covid Vaccine
India  /  Published 26.01.23

India gets its own nasal vaccine

The nasal vaccine -- BBV154 -- had received Drugs Controller General of India's approval in November for restricted emergency use among adults...
By Our Web Desk in New Delhi

India  /  Published 21.01.23

First Indian intranasal Covid jab to be launched on Jan 26

The company's chief also said that the homegrown jab for lumpy skin disease in cattle, Lumpi-ProVacInd, is likely to be launched next month...
By PTI in Bhopal

India  /  Published 14.01.23

Covishield: First lot set for dispatch

Since the launch of the anti-Covid vaccination drive, the company has so far provided 170 crore doses of Covishield to the govt...
By PTI in New Delhi

India  /  Published 12.01.23

Expert panel recommends market authorisation for Covovax

Prakash Kumar Singh, director at Serum Institute of India had recently written a letter to Drugs Controller General of India for approval...
By PTI in New Delhi

India  /  Published 10.01.23

Covovax booster dose decision likely on Wednesday

The DCGI had approved the SII's Covid vaccine for restricted use in emergency situations for adults on December 28, 2021...
By PTI in New Delhi


World  /  Published 10.01.23

Acceptance of Covid vaccines increased globally

The study underlines a wide variability among countries and the need for tailored communication strategies in addressing vaccine hesitancy...
By PTI in Washington

West Bengal  /  Published 29.12.22

15 lakh Covid jabs sought

State focus on vaccines, especially booster doses...
By Snehamoy Chakraborty in Calcutta

India  /  Published 23.12.22

Govt clears intranasal Covid vaccine

The approval for the vaccine comes amid a spurt in Covid cases in China and some other countries...
By PTI in New Delhi

India  /  Published 22.12.22

Serum Institute seeks usage approval of Covovax as booster dose

Covovax was approved by the DCGI for a restricted emergency use in children aged seven to 11 years in June...
By PTI in New Delhi

India  /  Published 28.11.22

Nasal Covid vaccine gets nod

The nasal delivery system has been designed and developed to be cost-effective in low- and middle-income countries...
By PTI in Hyderabad


Download our latest App

to get update on the go...


Copyright © 2020 The Telegraph. All rights reserved.